SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Introgen Therapeutics
An SI Board Since February 2004
Posts SubjectMarks Bans Symbol
802 21 0 INGN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
152innovations-report.com [these are from news.google.com. I am posting them to dezeta196112/9/2004
151Cancerpage.com cancerpage.comzeta196112/9/2004
150Made it in Forbes today forbes.comzeta196112/9/2004
149M.D.Anderson's PR Contact: Nancy Jensen, (713) 792-0655; nwjensen@mdandersozeta196112/9/2004
148Good morning Zeta, I'm seeing a bid above $10 for INGN this AM. Time to seIan@SI12/9/2004
147telegraph.co.uk Piece written about results delivered in San Antonio Injectionzeta196112/8/2004
146biz.yahoo.com Introgen Therapeutics, Inc. Announces $16 Million Financing Wednezeta196112/8/2004
145I obtained a PDF of the nano-particle/inflammation abstract...can email it to anzeta196111/29/2004
144Gopalan B, Ito I, Branch CD, Stephens C, Roth JA, Ramesh R. {from YMB..thoughtszeta196111/26/2004
143I received an immediate response from Dr. Posner..along with his paper with an ezeta196111/24/2004
142dana-farber.org My response to Dr. Posner...a snip..cut out my biographical/reszeta196111/23/2004
141Complete abstract for San Antonio Breast Cancer conference. [I hope they providzeta196111/23/2004
140wlns.com edit[thanks to Yahoo board poster] Interesting to read the lay personzeta196111/18/2004
139I'm quite excited about this one[edit: INGN 401].. Thanks Tuck.. Was browzeta196111/10/2004
138Those preliminary results on INGN401 look good !!! It may turn out to be even Jibacoa11/10/2004
137>>AUSTIN, Texas, Nov. 10 /PRNewswire-FirstCall/ -- Introgen Therapeutics, tuck11/10/2004
136Biological Response Modifiers Cmte. Renamed Cellular, Tissue and Gene Therapies zeta196111/9/2004
135Introgen Therapeutics Third Quarter 2004 Earnings Conference Call <i>[Berzeta196111/9/2004
134<<Yawn>> Chuckle ..actually..given the issues with Vioxx that apparzeta196111/8/2004
133[Advexin & Chemo in H&N cancer, in vitro study] >>AUSTIN, Texas, tuck11/8/2004
132I always thought that INGN 241 has an even greater potential than Advexin.<g&Jibacoa10/27/2004
131Mutant, wild type, or overall p53 expression: freedom from clinical progression zeta196110/26/2004
130A novel p21WAF1/CIP1 transcript is highly dependent on p53 for its basal expresszeta196110/21/2004
129Survivin regulates the p53 tumor suppressor gene family Space Zhanxiang Wang1,2,zeta196110/21/2004
128<i>And some more "news".<g>:</i> Nice to see youzeta196110/20/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News